Pharmaceutical Manufacturer Plans Massive Expansion

NEW HAVEN, CT — Alexion Pharmaceuticals plans to invest $10 million to expand its Global Product Development lab in New Haven, saying that the expansion represents an opportunity for Connecticut’s highly trained workers in a fast-growing sector, according to a statement from Gov. Ned Lamont. The project does not involve state incentives.

Alexion currently employees more than 500 workers in New Haven. The expansion is expected to be complete before the end of 2020.

“Connecticut has the most highly trained, best educated workers in the nation, and Alexion’s expansion of its New Haven laboratory signifies progress in our state’s bioscience industry and an opportunity to grow good paying, high quality jobs here,” Lamont said in a statement. “When a company of this size chooses to expand in our state, it signifies strength of the relationship between our state and this growing industry.”

Alexion said that the expansion at their 100 College Street building in New Haven is intended to increase the company’s capacity and capabilities to advance the development of more early medicine candidates from pre-clinical studies into clinical studies. It will also support the company’s ongoing efforts to develop new medicine delivery systems to improve patients’ treatment experiences, according to the statement.